PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain
|
|
- Suzanna Johns
- 5 years ago
- Views:
Transcription
1 Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name of originator/author, job title and department: Director Lead (Trust-wide policies) Associate Medical Director (local Policies) Clinical Management Team / Directorate Applicable to Name of responsible committee for the policy: Surgery CMTG Nirav Sheth Pharmacist Pharmacy Medical Director Surgery Date issued for publication: July 2013 Review date: April 2016 Expiry date: (Date 3 months following review date) Equality impact assessed by: (name, job title and department) Chris Moore Pharmacist Pharmacy Medicines Management Committee July 2016 Registration Requirements Outcome Outcome 9 Number(s) (CQC) NHSLA standard 5.10 This clinical guideline does not involve direct engagement with staff, patients, carers, visitors, the public or others and therefore does not require an Impact Assessment in line with Procedure D10a CNST standard N/A Page 1 of 14
2 CONTRIBUTION LIST Individuals involved in developing the document Name Nirav Sheth Chris Moore Rachel Revie Beverley Bone Designation Pharmacist Surgery Lead Pharmacist Lead Acute Pain Nurse Theatre recovery manager Circulated to the following individuals for consultation Name Linda Twohey Designation Consultant Anaesthetist Page 2 of 14
3 Approval and Authorisation Completion of the following signature blocks signifies the review and approval of this process. Name Job Title Signature Date Local Committee approval (where applicable) Name of Committee Name of Chairperson Surgery CMTG Mr Al-Hamali Date of Approval Change History Version Date Author Reason 3 Feb 2010 Beverly Bone Update to doses 3.1 Oct 2013 Document restored from archive and converted from Trust Policy format to Medicines Management Guideline format Impact Assessment This clinical guideline does not involve direct engagement with staff, patients, carers, visitors, the public or others and therefore does not require an Impact Assessment in line with Procedure D10a A translation service is available for this policy. The Interpretation/Translation Policy, Guidance for Staff (I55) is located on the library intranet under Trust wide policies. Contents Page 3 of 14
4 Section Page 1.0 Introduction Mild to moderate pain Severe pain Post-operative nausea and vomiting (PONV) Monitoring arrangements for compliance and effectiveness Plan for dissemination and implementation References 11 Appendix 1 Paracetamol doses at discharge 12 Appendix 2 NCA/PCA Morphine doses 13 Appendix 3 Codeine MHRA warning update 14 Page 4 of 14
5 1.0 Introduction These guidelines are focused on dosage ranges. For more comprehensive information the book BNF for Children should be consulted. Where information on doses has been taken from sources other than BNF for children (2012/13), this will be clearly identified in the text in blue italics. A patient group direction (PGD) on oral paracetamol prescribing for elective surgical patients on paediatric wards is available on the medicines management page of the hospital intranet. All post-operative analgesia prescriptions should not be given for longer than 48 hours without review. NOTE: The giving of INTRAMUSCULAR INJECTIONS is not normal practice on children unless there is no alternative route of administration. Analgesia given on the paediatric wards at KGH is only administered in the form of oral or rectal medication. All oral medication is administered using oral syringes, dedicated only for this purpose. Only syringes with purple plungers should be used for the administration of oral/enteral liquid medicines: There have been a number of deaths and serious incidents following administration of oral/enteral liquid medicines via the intravenous route (e.g. oramorph being drawn up in IV syringe and administered intravenously). All oral/enteral syringes should be labelled ( oral and/or enteral ) to aid selection and use. If not used immediately after preparation, the syringe must be labelled appropriately (name and strength of medicine, patient s name, date and time it was prepared by the person who has prepared the syringe). Post-operative INTRAVENOUS bolus opiate analgesia is only administered in the recovery room, where nurses have achieved the required competency under the Scope of Practice, and the immediate assistance of an anaesthetist is available. The appendices include dose-banding information regarding paracetamol and morphine PCA. The dose volumes cited indicate how pharmacy may round up/down prescribed doses of discharge medications, according to the body weight, to make it easier for parents and carers to administer at home. Page 5 of 14
6 2.0 MILD TO MODERATE PAIN PARACETAMOL Oral and Rectal loading dose: 30mg/kg. Refer to the following for subsequent (maintenance) dosing Oral (PO) AND rectal (PR) maintenance dosing Age 1 month 6 years 15mg 20mg /kg/dose hourly Max. daily dose: 90mg/kg in divided doses Age 6 12 years 15mg 20mg /kg/dose 4-6 hourly Max. daily dose: 90mg/kg in divided doses (Max 4g) Age years 1g every 4-6 hours Max 4 doses in 24 hours Intravenous (IV) dosing Weight < 10kg 7.5mg/kg/dose 4 6 hourly Max. daily dose: 30mg/kg in divided doses Weight 10 50kg 15mg/kg/dose 4 6 hourly Max. daily dose: 60mg/kg in divided doses Weight > 50kg 1g 4 6 hourly Max. daily dose: 4g in divided doses The above doses should be given for a maximum of 48 hours before review Rectal dosing choose the nearest suppository strength and adjust frequency so total daily dose is not exceeded. Intravenous administration give as an infusion over 15 minutes. A 50ml (500mg) vial can be further diluted with 0.9% Sodium Chloride or 5% Glucose to a maximum volume of 500ml If different preparations are required, prescribe as separate entries on the PRN medication section of the drug chart with the corresponding dose for each route. CAUTIONS Renal impairment: Increase infusion dose interval to every 6 hours if egfr < 30ml/min Hepatic impairment: High risk of liver toxicity with high doses in patient with chronic malnutrition, dehydration. Reduce max. daily infusion dose to 3g in divided doses Page 6 of 14
7 IBUPROFEN Oral (PO) maintenance dosing Age 1 3 months 5mg/kg/dose 6-8 hourly Age > 3 months 5 10mg/kg/dose 6-8 hourly Max. daily dose: 30mg/kg in divided doses (up to max. 2.4g daily) Doses from Leicester Royal Infirmary Children s Hospital Paediatric analgesia guidelines and BNFC (12/13) CAUTIONS Renal impairment: Use with caution with monitoring or renal function. Hepatic or cardiac impairment: Use with caution. Children with asthma: Use with caution with monitoring of respiratory function. DICLOFENAC Oral (PO) and rectal (PR) maintenance dosing Age < 6 months Age 6 months NOT RECOMMENDED 0.3 1mg/kg/dose (max 50mg total dose) 8 hourly Max. daily dose: 3mg/kg/24 hours or 150mg in divided doses Rectal dosing choose the nearest suppository strength to the weight and adjust frequency so total daily dose is not exceeded. CAUTIONS (See above, as for ibuprofen) CODEINE PHOSPHATE Oral (PO) maintenance dosing (Tablets are not licensed for use in children < 12 years; Intravenous (IV) route should be avoided - causes histamine release, resulting in reduced cardiac output) Dose 0.5 1mg/kg/dose 4-6 hourly Max. daily dose: 240mg in divided doses CAUTIONS PLEASE CONSULT APPENDIX 3 FOR THE LATEST MHRA CONTRAINDICATIONS RELATING TO AGE AND INDICATIONS Page 7 of 14
8 3.0 SEVERE PAIN MORPHINE SULPHATE Oral (PO) maintenance dosing (using 10mg/5ml oral solution not licensed for use in children < 1 year) Age 1 12 months micrograms/kg/dose up to 4 hourly Age 1 2 years micrograms/kg/dose up to 4 hourly Age 2 12 years micrograms/kg/dose up to 4 hourly (Maximum 20mg/dose) Age years 5mg 20mg dose Doses from Leicester Royal Infirmary Children s Hospital Paediatric analgesia guidelines Intravenous (IV) Bolus dosing Max. daily dose: 2.5mg/kg/24hours (Max. 6 doses in 24 hours) Use lowest dose first. Age < 1 month Age 1 6 months Age 6 months 12 years Age years 50 micrograms/kg/dose 6 hourly 100 micrograms/kg/dose 6 hourly 100 micrograms/kg/dose 4-6 hourly 5mg 10mg 4-6 hourly Administration: Intravenous bolus given over at least 5 minutes. Use lowest dose first. Doses from BNFC 12/13 Intravenous (IV) administration via PCA pump Weight < 50kg Total amount of morphine = 1mg/kg (up to max. 50mg), in 50ml normal saline to give final concentration of 20mcg/kg/ml Loading dose volume (prior to starting PCA) = 2.5 5ml STAT Bolus dose volume = 1ml, followed by 5-minute lockout period Weight 50kg Use 50mg/50ml pre-filled syringe See above for dose volumes, as for patient weight < 50kg Doses from Leicester Royal Infirmary Children s Hospital Paediatric analgesia guidelines Examples: Child weighing 33kg = 33mg morphine sulphate made up to 50ml Sodium Chloride 0.9% Child weighing 44kg = 44mg morphine sulphate made up to 50ml Sodium Chloride 0.9% Child weighing 55kg = Use 50mg/50ml pre-filled syringe Page 8 of 14
9 CAUTIONS (See codeine phosphate) High risk of respiratory depression in children < 12 months. Monitor respiratory rate after each dose, consider monitoring of oxygen saturation. RESPIRATORY MONITORING IS ESSENTIAL!!! PETHIDINE Pethidine may be used if there are known sensitivities to morphine administration. Oral (PO) dosing (for smaller doses, the injection may be given orally) Age: 2 months - 12 years Age 12 years 500micrograms 2mg/kg/dose 4-6 hourly PRN mg 4-6 hourly PRN Maximum 1mg/kg/dose 12 hourly for neonates increased susceptibility to respiratory depression Doses from Medicines for Children (2003) Intravenous (IV) dosing Age < 12 years 500 micrograms 1mg/kg/dose 4-6 hourly PRN (12 hourly if less than 2 months old) Age 12 years 25 50mg 4-6 hourly PRN Doses from Medicines for Children (2003) Minimum 12 hourly dosing for neonates increased susceptibility to respiratory depression CAUTIONS Avoid in severe renal and hepatic impairment High risk of respiratory depression in children < 12 months. Monitor respiratory rate after each dose, consider monitoring of oxygen saturation. Page 9 of 14
10 NALOXONE To be used in cases of over-dosage with opioids or post-operative respiratory depression Intravenous (IV) bolus dosing Age < 12 years 1 microgram /kg/dose Repeat every 2 3 minutes if required Age 12 years 1.5 microgram 3 microgram/kg/dose If response inadequate give subsequent doses of 100 micrograms every 2 3 minutes if required 4.0 POST-OPERATIVE NAUSEA & VOMITING (PONV) Anti-emetics given intra-operatively will help in the prevention of PONV, particularly when opioid analgesia has been used. Ondansetron is the drug of choice, because cyclizine injection is not licensed for use in children. However, the use of cyclizine is effective and common in young children. ONDANSETRON Intravenous (IV) bolus dosing Age: > 1 month 18 years 100 micrograms /kg /dose 8 hourly (Max. 4mg/dose) Administration: Intravenous bolus given over 2 5 minutes. CYCLIZINE By Mouth OR Intravenous (IV) bolus dosing Age 1 month 6 years Age 6 12 years Age years 0.5 1mg/kg/dose 8 hourly (Max. 25mg/dose) 25mg 8 hourly 50mg 8 hourly Administration: Intravenous bolus given over at 3 5 minutes. Page 10 of 14
11 5.0 MONITORING ARRANGEMENTS FOR COMPLIANCE AND EFFECTIVENESS Aspect of compliance or effectiveness being monitored The document is intended to guide prescribers. Adherence is not mandatory and so compliance monitoring is not required. Monitoring method See above Responsibility for monitoring See above Frequency of monitoring See above Responsible committee for monitoring and implementation of required actions See above 6.0 PLAN FOR DISSEMINATION AND IMPLEMENTATION This guideline will be implemented and disseminated via the following methods: Placed on the hospital intranet sites briefing to relevant clinicians and pharmacy staff 7.0 References: 1. Medicines Management Clinical Committee (2007) 2. BNF for children: BMJ publishing Group Ltd (2012/13) 3. Guy s and St Thomas, King s College and University Lewisham Hospitals Paediatric Formulary 7 th Edition (2005) 4. NGH NHS Trust: Children s Unit, Guidelines for Children s Pain Management. Compiled by J Margetts (2002) 5. Medicines for Children. Royal College of Paediatrics and Child Health (2003) 6. Leicester Royal Infirmary Children s Hospital Paediatric Analgesia Guidelines (2009) Page 11 of 14
12 Appendix 1 Paracetamol doses at discharge Oral dose: 15mg/kg every 4-6 hours. Maximum 90mg/kg or 4g/day Weight Dose Frequency Max m dose (kg) (mg) Oral Rectal q 6-8hours 60mg/kg/ q 6-8hours day in divided doses q 6-8hours qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses qds 4 doses g 500-1g qds 4 doses Page 12 of 14
13 Appendix 2 NCA/PCA Morphine Doses Weight (kg) Dose (mg / 50ml) Dose (microgram/ml) (1mg) Page 13 of 14
14 Appendix 3 Codeine MHRA warning update Advice for healthcare professionals: Codeine should only be used to relieve acute moderate pain in children older than 12 years and only if it cannot be relieved by other painkillers such as paracetamol or ibuprofen alone Codeine is now contraindicated in: all children age 0 18 years who undergo tonsillectomy or adenoidectomy (or both) for obstructive sleep apnoea all patients of any age known to be CYP2D6 ultra-rapid metabolisers Codeine is not recommended for use in children whose breathing might be compromised, including those with: neuromuscular disorders; severe cardiac or respiratory conditions; upper respiratory or lung infections; multiple trauma; or extensive surgical procedures. Morphine toxicity may be increased in these settings In children age years, the maximum daily dose should not exceed 240 mg. This may be taken in divided doses up to four times a day at intervals of no less than 6 hours. It should be used at the lowest effective dose for the shortest period. Duration of treatment should be limited to 3 days and if no effective pain relief is achieved, treatment should be reviewed by a physician Information should be given to parents and caregivers on how to recognise the signs and symptoms of morphine toxicity, and advice should be given to stop giving the child codeine and to seek medical attention immediately if the child shows these signs or symptoms, which include: reduced levels of consciousness; somnolence; respiratory depression; pin-point pupils; lack of appetite; constipation; or nausea and vomiting Page 14 of 14
Index No: MMG11/1. Version: 1. Date ratified: 12 th November 2013
Index No: Intravenous fluid prescription in children For previously well children aged one month to 16 years (excluding renal, cardiac, diabetic ketoacidosis and acute burns patients) Version: 1 Date ratified:
More informationGuidelines on the Administration of Paracetamol in Children
DERBY HOSPITALS NHS FOUNDATION TRUST DIVISION OF INTEGRATED MEDICINE PAEDIATRICS Guidelines on the Administration of Paracetamol in Children REF NO: CH PH GE 17 Reference Number: CH PH GE 17 Version: 5
More informationADULT (>16) ACUTE SICKLE PAIN GUIDELINE
ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ID 2013 065 Author s Name Dr Anna Wood Author s Job Title Consultant Haematologist Division Consultant Haematologist Department Haematology Version number 3 Ratifying
More informationContributes to CQC Outcome number: 9&12 Consulted With Post/Committee/Group Date. Pharmacist. Alison Felton Head of Pharmacy/Deputy Chief.
Prescribing paracetamol in adult inpatients at MEHT Type: Clinical Guideline Register No: 18005 Status: Public on ratification Developed in response to: In line with Basildon Contributes to CQC Outcome
More informationCLINICAL GUIDELINES ID TAG
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Guideline for the management of pain in children Kieran O Connor Anaesthetics ATICS Date Uploaded: 1 September 2016 Review
More informationCodeine and Paracetamol in Paediatric use, an Update 5 th October 2013
Codeine and Paracetamol in Paediatric use, an Update 5 th October 2013 This guidance should be read in parallel to the detailed guidelines on pain management in children (APA guidelines) 2 nd edition.
More informationTrust Guideline for the Management of Patient Controlled Analgesia (PCA) in Adults
Patient Controlled Analgesia (PCA) in Adults A clinical guideline recommended for use For Use in: In all Clinical Areas By: Anaesthetists, Ward Nurses, Recovery Staff Acute Pain Service Staff For: Adult
More informationAnnex III. Amendments to relevant sections of the product information
Annex III Amendments to relevant sections of the product information Note: These amendments to the relevant sections of the Summary of Product Characteristics and Package Leaflet are the outcome of the
More informationGuidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas aeruginosa Lung Infections in Adults
Index No: MMG41 Guidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas Version: 2 Date ratified: November 2017 Ratified by: (Name of Committee) Name of originator/author,
More informationGuidelines for acute treatment of patients with Parkinson s disease including those who are nil by mouth
Index No: MMG48 Guidelines for acute treatment of patients with Parkinson s disease including those who are nil by mouth Version: 2.0 Date ratified: November 2017 Ratified by: (Name of Committee) Name
More informationIntravenous Iloprost Guidelines. November 2020
Index No: MMG31 (Formerly MM31) Intravenous Iloprost Guidelines Version: 3.0 Date ratified: Ratified by: (Name of Committee) Name of originator/author, job title and department: November 2017 Medicines
More informationPaediatric Prescribing Pocket Guide September 2014 (Version 1)
PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationAcute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)
Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Introduction The majority of acute painful crises in patients with sickle cell disease will be managed independently
More informationAlgorithms for Symptom Management. In End of Life Care
Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the
More informationBJF Acute Pain Team Formulary Group
Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution
More informationChildren & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet
1 Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Name of Guideline / Policy/ Procedure MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Purpose of Procedure/
More informationPrescribing and Administration of Analgesia within Maternity
Prescribing and Administration of Analgesia within Maternity CONTENTS Introduction and Who The Guideline Applies To... 2 UHL Paracetamol Prescribing Guideline... 2 Oral dosing... 2 Intravenous dosing...
More informationDOCUMENT CONTROL PAGE
DOCUMENT CONTROL PAGE Title Title: Version: 3 Reference Number: Supersedes Supersedes: All previous versions (2006) Description of Amendment(s): New hospital contact details applied. Originator or modifier
More informationDocument Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml
Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of
More informationClinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol
Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol 1. Aim/Purpose of this Guideline 1.1. To Provide safe and efficient administration of Opioids in Recovery.
More informationGuideline for the Post Operative Management of Women who have received Intrathecal or Epidural Opioid Analgesia for Caesarean Section
Guideline for the Post Operative Management of Women who have received Intrathecal or Epidural Opioid Analgesia for Caesarean Section Speciality: Maternity Approval Body: Labour Ward Forum Approval Date:
More informationNHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults. Consultation Group: See Page 5
NHS...... Grampian Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery in Adults Co-ordinators: Consultant Anaesthetist, Lead Acute Pain
More informationNHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery
Acute Sector NHS Grampian Protocol For The Prescribing And Administration Of Oral Opioids Following Trauma Or Surgery Co-ordinators: Dr Karen Cranfield, Consultant Anaesthetist, Lead Acute Pain Sector
More informationMid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
More informationSedation in Children
CHILDREN S SERVICES Sedation in Children See text for full explanation and drug doses Patient for Sedation Appropriate staffing Resuscitation equipment available Monitoring equipment Patient suitability
More informationTrust Guideline for the Management of Patient Controlled Analgesia (PCA) or Nurse Controlled Analgesia (NCA) in Children
Clinical Guideline For Use in: By: For: All clinical areas Anaesthetists, Nursing staff, Acute Pain Service Paediatric patients(up to the age of 16) receiving PCA or NCA Division responsible for document:
More informationDay care adenotonsillectomy in sleep apnoea
Day care adenotonsillectomy in sleep apnoea Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Day care adenotonsillectomy in presence of sleep apnoea 1a 2a 2b Contact
More informationpatient group direction
CYCLIZINE v01 1/7 CYCLIZINE PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)
More informationGUIDELINE FOR THE POST OPERATIVE MANAGEMENT OF WOMEN WHO HAVE RECEIVED INTRATHECAL OR EPIDURAL OPIOID ANALGESIA FOR CAESAREAN SECTION
GUIDELINE FOR THE POST OPERATIVE MANAGEMENT OF WOMEN WHO HAVE RECEIVED INTRATHECAL OR EPIDURAL OPIOID ANALGESIA FOR CAESAREAN SECTION Originator: Maternity Services & Anaesthetics Dept Date Approved: January
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More information(30689) PROT Pain PCA Adult Patient Controlled Analgesia
Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory
More informationFrequently Asked Questions
Page 1 Frequently Asked Questions Codeine and all multiple-ingredient products containing codeine are restricted on the AHS Provincial Drug Formulary to patients 18 years of age and older. 1. What does
More informationAppendix: Sample prescription form. The following sample prescription form gives examples of sections found in most hospital prescription forms.
The hands-on guide to practical prescribing Oliver Jones, Nandan Gautam Copyright 2004 by Blackwell Publishing Appendix: Sample prescription form The following sample prescription form gives examples of
More informationPATIENT GROUP DIRECTION (PGD)
PATIENT GROUP DIRECTION (PGD) SUPPLY OF NALOXONE HYDROCHLORIDE INJECTION BY REGISTERED NURSES TO CLIENTS BEING RELEASED FROM HMP FORD Version Number: 01HMP Patient Group Direction originally drawn up by:
More information[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]
[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose
More informationPAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationPAIN MANAGEMENT Person established taking oral morphine or opioid naive.
PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More informationGuideline for the use of Clonidine for Sedation in Adult Intensive Care
Guideline for the use of Clonidine for Sedation in Adult Intensive Care This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the
More informationBerkshire West Area Prescribing Committee Guidance
Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for
More informationDOCUMENT CONTROL PAGE
DOCUMENT CONTROL PAGE Title: Analgesia Guidelines for Infants Undergoing Title Version: 3 Reference Number: Supersedes Supersedes: Version 2 Significant Changes: Inclusion of algorithm Originator or modifier
More informationEnd of life prescribing guidance
End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly
More informationPAIN PODCAST SHOW NOTES:
PAIN PODCAST SHOW NOTES: Dallas Holladay, DO Ultrasound Fellow Cook County Hospital Rush University Medical Center Jonathan D. Alterie, DO PGY-2, Emergency Medicine Midwestern University An overview of
More informationExcellent Care with Compassion
Pain Relief Pain relief for your child following surgery Information for parents and carers Excellent Care with Compassion This leaflet contains information to help you manage your child s pain at home.
More informationClinician Responsible for Training and Review: Emergency Department Consultant
Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This
More informationPCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING
Attach ADR Sticker THESE INSTRUCTIONS EXPLAIN WHEN TO MAKE A CLINICAL REVIEW OR RAPID RESPONSE CALL, YOUR LOCAL ESCALATION PROTOCOL WILL EXPLAIN HOW TO MAKE A CALL PCA ALLERGIES & ADVERSE DRUG REACTIONS
More informationGuidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)
Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More information5 MUSCULOSKELETAL SYSTEM
5 MUSCULOSKELETAL SYSTEM 5.01 NON-STEROIDAL ANTIILAMMATORY DRUGS (NSAIDS) *Acetylsalicylic Acid (Aspirin) Tab Soluble 300mg Diclofenac Sodium Tab 25mg, Supp 25mg, 50mg & 100mg (Voltaren) 300-900mg every
More informationPAEDIATRIC NERVE BLOCK / WOUND INFILTRATION
PAEDIATRIC NERVE BLOCK / WOUND INFILTRATION Addendum to the MULTIDISCIPLINARY GUIDELINES FOR ACUTE PAIN MANAGEMENT IN CHILDREN AND YOUNG PEOPLE Policy Owner: Approved by: Ratified by: ABMU HB Pain Management
More informationCLINICAL POLICY FOR THE USE OF INTRANASAL DIAMORPHINE FOR ANALGESIA IN CHILDREN ATTENDING THE PAEDIATRIC EMERGENCY DEPARTMENT, SASH
CLINICAL POLICY FOR THE USE OF INTRANASAL DIAMORPHINE FOR ANALGESIA IN CHILDREN ATTENDING THE PAEDIATRIC EMERGENCY DEPARTMENT, SASH Background Adequate analgesia is a vital aspect of early management of
More informationA Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children
For Use in: By: For: Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager: Supported by: Assessed and approved by the:
More informationPAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE
PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A
More informationGuideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use
Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document
More informationUNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016
ljs7 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085
More informationMORPHINE ADMINISTRATION
Introduction Individualised Administration Drug of Choice Route of Administration & Doses Monitoring of Neonates & high risk patients Team Management Responsibility Morphine Protocol Flow Chart Introduction
More informationPAEDIATRIC ANALGESIA GUIDELINES
PAEDIATRIC ANALGESIA GUIDELINES V5.2 Sept 2017 Paediatric Analgesia Guidelines Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary...
More informationMANAGEMENT OF PATIENTS WITH PARKINSON S DISEASE WHO ARE NIL BY MOUTH OR WITH A COMPROMISED SWALLOW
MANAGEMENT OF PATIENTS WITH PARKINSON S DISEASE WHO ARE NIL BY MOUTH OR WITH A COMPROMISED SWALLOW Author: Gordon W Duncan Status: Approved Authorised by: Clinical Policy Group Version: 1.0 Review date:
More informationTitle: Improving the patient experience for children with Sickle Cell Disease Author/Responsible Director: Carole Ribbins Director of Nursing
Trust Board Paper S To: Trust Board From: Kate Wilkins Divisional Head of Nursing Hilliary Killer Children s CBU Nurse Lead and General Manager Liz James Matron, Children s CBU Date: 28 March 2013 All
More informationCare of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
More informationUNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17
LJW3 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085
More informationPolicy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04
Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating
More informationDOCUMENT CONTROL PAGE
DOCUMENT CONTROL PAGE Title Title: UNDERGOING SPINAL DEFORMITY SURGERY Version: 2 Reference Number: Supersedes Supersedes: all other versions Description of Amendment(s): Revision of analgesia requirements
More informationClinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults
Clinical Guideline Guidelines for the use of opioid analgesics in the management of acute pain in adults Document detail Document location West Kent and MTW Formulary Version 1.0 Effective from July 2017
More informationPalliative Care Out-of-hours. A resource pack for West Dorset. Contents:
Palliative Care Out-of-hours. A resource pack for West Dorset Contents: Section 1 Supply of drugs DCH Pharmacy hours and arrangements How to contact a community pharmacist out of hours Palliative care
More informationPain Management for Adult sickle cell disease patients: Information for patients, relatives and carers
Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers Why you should read this leaflet This leaflet will give you the information necessary to manage your
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationPHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS
PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationCLINICAL GUIDELINES ID TAG
CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Guideline for the perioperative fluid management in children Kieran O Connor Anaesthetics ATICS Date Uploaded: 26/04/2016 Review
More informationpatient group direction
MORPHINE SULPHATE (Oral) v01 1/8 MORPHINE SULPHATE (Oral) PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic)
More informationPain relief after surgery. Patient Information
Pain relief after surgery Patient Information Author ID: JT Leaflet Number: Pain 003 Version: 5 Name of Leaflet: Pain after surgery Date Produced: April 2017 Review Date: April 2019 This leaflet describes
More informationAdult Opioid Prescribing Guidelines for Acute or Persistent Pain
Adult Opioid Prescribing Guidelines for Acute or Persistent Pain Author: Sponsor/Executive: Responsible committee: Consultation & Approval: (Committee/Groups which signed off the policy, including date)
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More informationpatient group direction
ACICLOVIR v01 1/8 ACICLOVIR PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)
More informationPackage leaflet: Information for the patient. Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate
Package leaflet: Information for the patient Morphine Unimedic 1 mg/ml solution for injection morphine hydrochloride trihydrate Read all of this leaflet carefully before you start using this medicine because
More informationpatient group direction
PRESERVATIVE-FREE LIDOCAINE v1.0 1/9 PRESERVATIVE-FREE LIDOCAINE PGD Details Version 1.0 Legal category Staff grades Approved by POM Registered Paramedic Registered Nurse Medicines Management Group Date
More information** Medication exercises ** NICU Phase II
** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Post-op, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She
More informationLRI Children s Hospital
LRI Children s Hospital Guideline for the Care of Neonates, Children and Young People Requiring Epidural Analgesia Staff relevant to: All Health Professionals who care for neonates, children and young
More informationAnalgesia in patients with impaired renal function Formulary Guidance
Analgesia in patients with impaired renal function Formulary Guidance Approved by Trust D&TC: January 2010 Revised March 2017 Contents Paragraph Page 1 Aim 4 2 Introduction 4 3 Assessment of renal function
More informationMMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
More informationPENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE
PENNINE LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Originally produced: July 2006 First Review: August 2009 Second Review: November 2011 For review November 2013 Approved
More informationSUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:
FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full
More informationEAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE
EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved
More informationCare in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
More informationPain Management after Discharge from Hospital
Pain Management after Discharge from Hospital South Tyneside Anaesthetics Department and Acute Pain Services 1 Part of: South Tyneside and Sunderland Healthcare Group 2 Information for patients This leaflet
More informationGuidance For The Use Of Naltrexone In The Maintenance Of Abstinence in Formerly Opioid Dependent Adults By Clinicians Working Within NHS Grampian
Title: Identifier: Guidance For The Use Of Naltrexone In The Maintenance Of Abstinence in Formerly Opioid Dependent Adults By Clinicians Working Within NHS Grampian NHSG/Guide/NHSG_NaltexMA_885 Replaces:
More informationSALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department
More informationLET - Maths, Stats & Numeracy
Metric Conversions Here are some metric weights arranged in size order, starting with the biggest:- Kg (kilogram) g (gram) mg (milligram) mcg (microgram) Each one is a thousand (1000) times smaller than
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase: Pediatric Spine Surgery General Orders
- Phase: Pediatric Spine Surgery General Orders PHYSICIAN S Diagnosis Weight Allergies Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert
More informationSHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN
SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the
More informationMedicines to treat pain in adults. Information for patients and carers
Medicines to treat pain in adults Information for patients and carers It is common to feel some pain after having an operation (surgery), trauma or an infection. Controlling pain is an important part of
More informationdressing changes in adults and children. Contributes to CQC Outcome number: 4
Administering Intra-Nasal Diamorphine to Burns Patients Clinical Guideline Trust Register No: 09072 Status: Public Developed in response to: Improving efficacy of analgesia for burns dressing changes in
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationGuidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings
Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings NHS Highland Authorised by: Planning For Fairness: Yes/No (Formerly EQIA) Distribution Consultant
More information21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content
Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for
More informationCommon Infusions for Neonatal Use
Common Infusions for Neonatal Use Document Title and Reference : Common Infusions for Neonatal Use Main Author (s) Dr N B Soni Ratified by: LSC CEG Date Ratified: May 2016 Review Date: May 2018 Version:
More informationPATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION
PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION CLASSIFICATION OF DOCUMENT: PURPOSE: Patient Group Direction Document
More information